ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NSCI Netscientific Plc

71.50
0.50 (0.70%)
Last Updated: 08:07:18
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.70% 71.50 6,952 08:07:18
Bid Price Offer Price High Price Low Price Open Price
70.00 73.00 71.50 69.75 71.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1292 -5.50 17M
Last Trade Time Trade Type Trade Size Trade Price Currency
08:07:14 O 6,952 71.377 GBX

Netscientific (NSCI) Latest News

Netscientific (NSCI) Discussions and Chat

Netscientific Forums and Chat

Date Time Title Posts
12/7/202414:51NetScientific PLC5,918
24/1/202119:11NETSCIENTIFIC10
15/6/201911:31Netscientific16

Add a New Thread

Netscientific (NSCI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:07:1671.386,9524,962.13O

Netscientific (NSCI) Top Chat Posts

Top Posts
Posted at 15/7/2024 09:20 by Netscientific Daily Update
Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 71p.
Netscientific currently has 23,945,828 shares in issue. The market capitalisation of Netscientific is £17,001,538.
Netscientific has a price to earnings ratio (PE ratio) of -5.50.
This morning NSCI shares opened at 71p
Posted at 07/7/2024 00:17 by kingston78
My previous summary that the company was trading at the top of its band at 79 p has been proven correct. The share price has since dropped back to 70-72 p.

A wife was complaining to her friends that whilst her husband's business was doing well she did not see any improvement in their standard of living. Some years later when her husband cashed in his business they suddenly became cash millionaires.

NSCI (or rather us investors)is like the wife described above. Asset rich but cash poor. Dragon's Den will ask a simple question, "show me the cash". Value may rise and value may fall. Only cash is king.

As reiterated before, NSCI will only rise substantially if a large investor continues to buy its shares to push up the price, or a large profitable cash exit from one or more of its investments will pave the way upwards. Small investors have little influence.
Posted at 26/6/2024 18:17 by kingston78
NSCI is always lightly traded, so there cannot be many followers or new investors. I think that there is a lack of promotion to the right audience.

Despite MM has marked down the price by 1p today the spread has narrowed from 6p to only 1 p (72-73p). It would appear that MM wants sellers to sell them the stock, as they keep a tight book. In this respect, any pent up demand generated by, for example, an investment recommendation by IC or others, will raise the share price by a few pence.

Anyway, as I have iterated before, unless and until the company has realised real cash in exiting one or more of its investments the share price will reach 90 p - 100 p at best in the next few months. If achieved, that is not a bad return.

Years ago, I realised that investment trusts were mostly trading at a discount to their underlying assets whilst Unit Trusts were trading at a premium. This is a perception issue. NSCI is acting like an investment trust, investing in a number of companies that may generate a good return.

I have no doubt in my mind that one day, we only need a blockbuster to increase the value of NSCI many folds. We live in hope.
Posted at 25/6/2024 10:15 by kingston78
If Merck were to bid for PDSB at its lowest point in terms of share price (it was US$14 now less than US$3), with a likely chance of success medically, it would be a great gamble for Merck. This is the cheapest route to the drug being developed by PDSB.

NSCI will therefore crystallise its investment in PDSB, hopefully at least breakeven, but get some cash in its coffer.
Posted at 14/6/2024 19:26 by kingston78
Please refer to my speculation and comment on my previous post that we need a wealthy individual to take a large stake to get the share price going. Now someone has a 3% stake, and he may be accumulating to push towards 5% or even 10%. The share price will jump and this guy will benefit greatly as well as all of us.
Posted at 14/6/2024 09:54 by kingston78
The company needs a wealthy private individual to take a large stake to move the share price going.

I am sure that the directors are working hard to try to exit one or more of its portfolio companies.

The market condition is not right at present. In the heyday, any one of its portfolio companies could be listed as a young high tech company, with a market cap probably exceeding that of the entire NSCI. Those were the days when you could throw a dart onto a financial newspaper listing and buy any company to make a profit.
Posted at 13/6/2024 11:18 by kingston78
The important factor was that when PDSB was at a high of US$14 the share price of NSCI had hardly progressed. Subsequent events have shown that NSCI has become a more rounded investment companies with a promising portfolio of high tech companies at their early stage. Moreover, NSCI does not contribute much in cash term the advancement of those companies, which rely on external funding, which at a higher subscription price, actually adds value to NSCI despite the fact that they are unlisted. One of these days there will be a profitable exit, or exits, and investors will see that NSCI has many gems. This is akin to some people who are asset rich but cash poor.

I am just concerned that NSCI will not have sufficient cash to run its corporate activities and resort to a discounted fund raising itself.
Posted at 10/5/2024 09:31 by senttothegallows
Utter rubbish being posted here. Pdsb released news very late last night from then Nsci have to get their nomad to approve and post. Nsci unlikely to move as it seems holders and the market are unable to grasp the value in something where assets are more than 3 times the share price.
Ultimately good news at pdsb
Posted at 01/5/2024 16:20 by loafofbread
Looking at IP GROUP discount to NAV.

They have gone down the share buy back route which is 100% where NSCI should be looking to close the gap between the 60p share price and the £2.00 NAV.

Why invest money elsewhere when you can effectively buy assets at a 200% discount!

Continued commitment to shareholder returns

- Launched further £20m share buyback fulfilling our commitment to regular cash returns from realisations

- As announced on 18 December 2023, future cash returns are expected to be in the form of share buybacks when the share price discount to NAV exceeds 20%
Posted at 17/11/2023 08:17 by loafofbread
Much easier if they just posted a normal spread on NSCI.

Another £500K increase in PDSB.

NSCI share price is so far behind fair value it's unreal.
Posted at 31/5/2023 16:57 by blakieboy7
PDSB now up over 9 dollars, not that it's making FA difference to NSCI share price!! That's over 5.5% up so far
Netscientific share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock